Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Sopa Images | Lightrocket | Getty ImagesBluebird Bio will sell itself to private equity firms Carlyle and SK Capital for ...
Tag: Health care industry
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California ...
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.Kelly Sullivan | Getty ...
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersThe long-running U.S. shortage ...
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced ...
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding
Prenuvo's clinic in New York City, New York.Courtesy of PrenuvoPreventative health startup Prenuvo on Thursday announced it will offer three ...
Neuralink competitor Paradromics secures investment from Saudi Arabia’s Neom
Paradromics' Connexus Direct Data Interface.Courtesy: ParadromicsTexas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia's Neom and ...
Doximity shares soar 25% after company beats on revenue, raises fiscal-year guidance
Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.Source: NYSEShares of Doximity popped ...
Doximity shares pop 36% on revenue beat, rosy guidance
Piotr Swat | Lightrocket | Getty ImagesDoximity shares closed up 36% on Friday, a day after the company reported fiscal ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that's slated to run ...
